Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human_leishmaniasis/cytokines.bahia.br

M Barral-Netto1, C Brodskyn, E M Carvalho

  • 1Centro de Pesquisas Gonçalo Moniz, FIOCRUZ, Salvador, BA, Brasil. barral@ufba.br

Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas
|August 1, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Possible biases in Roh et al.'s article about the association between COVID-19 vaccination and Alzheimer's disease.

QJM : monthly journal of the Association of Physicians·2024
Same author

The Centre for Data and Knowledge Integration for Health (CIDACS): Linking Health and Social Data in Brazil.

International journal of population data science·2021
Same author

Presence of parasite DNA in clinically unaffected nasal mucosa during cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2019
Same author

Determination of avidity of IgG against protein antigens from Streptococcus pneumoniae: assay development and preliminary application in clinical settings.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2017
Same author

Effector memory CD4(+) T cells differentially express activation associated molecules depending on the duration of American cutaneous leishmaniasis lesions.

Clinical and experimental immunology·2016
Same author

Experimental manipulation of leaf litter colonization by aquatic invertebrates in a third order tropical stream.

Brazilian journal of biology = Revista brasleira de biologia·2015

Understanding cytokine balance is key for leishmaniasis treatment. Interleukin-10 (IL-10) hinders immune responses, while Interleukin-12 (IL-12) boosts them, offering therapeutic potential.

Area of Science:

  • Immunology
  • Parasitology
  • Infectious Diseases

Background:

  • Cell-mediated immunity is crucial for leishmaniasis resistance and recovery.
  • Cytokines, like interferon-gamma (IFN-gamma), are central to immune responses in leishmaniasis.
  • IFN-gamma activates macrophages for leishmanicidal mechanisms.

Purpose of the Study:

  • To investigate the cytokine balance in human leishmaniasis.
  • To evaluate the roles of IL-10 (IFN-gamma opposing) and IL-12 (IFN-gamma inducer) in leishmaniasis.
  • To assess the impact of these cytokines on human immune response parameters.

Main Methods:

  • Evaluation of cytokine effects on lymphocyte proliferation, IFN-gamma production, and cytotoxic activity.
  • Neutralization of IL-10 in peripheral blood mononuclear cells from visceral leishmaniasis patients.

Related Experiment Videos

  • Assessment of IL-12's restorative effects on immune cells from leishmaniasis patients.

    • Main Results:

    • IL-10 reduced lymphocyte proliferation, IFN-gamma production, and cytotoxic activity.
    • IL-10 neutralization partially restored immune responses in unresponsive leishmaniasis patients.
    • IL-12 effectively restored immune cell responses, showing greater efficacy than IL-10 neutralization.

    Conclusions:

    • Cytokine balance, particularly involving IL-10 and IL-12, significantly impacts leishmaniasis immunity.
    • IL-10 acts as an immunosuppressive cytokine in leishmaniasis.
    • IL-12 demonstrates potent immunotherapeutic potential for leishmaniasis by restoring cell-mediated immunity.